Target Name: MIR17HG
NCBI ID: G407975
Other Name(s): MIR17HG variant 1 | miR-17-92 | MIRHG1 | miR-17-92a-1 cluster host gene | MiR-17-92a-1 cluster host gene, transcript variant 1 | MGC126270 | LINC00048 | NCRNA00048 | C13orf25 | MIRH1 | ONCOMIR1 | FGLDS2 | MIHG1 | FLJ14178

MIR17HG: A Non-Coding RNA Molecule as A Potential Drug Target Or Biomarker

MIR17HG, also known as MIR17HG variant 1, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for several diseases, including cancer. MIR17HG is a member of the MIR17 family of non-coding RNAs, which have has been shown to play important roles in various cellular processes, including gene regulation, RNA homeostasis, and cell survival.

MIR17HG is characterized by its unique structure, which consists of a long single-stranded RNA molecule that is composed of 20 exons. The molecule has a highly conserved nucleotide sequence, with the exception of a single nucleotide deletion at position 16, which results in a substitution of G for C at that position. This deletion has been shown to have a significant impact on the stability and function of the molecule.

MIR17HG has been shown to play a role in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. For example, studies have shown that MIR17HG is involved in the regulation of cell cycle progression, and that it plays a role in the detoxification of environmental toxins.

In addition to its role in cellular processes, MIR17HG has also been shown to be a potential drug target or biomarker for several diseases, including cancer. For example, studies have shown that MIR17HG is overexpressed in various types of cancer, and that inhibition of the MIR17HG gene has been shown to have therapeutic effects in these diseases.

The MIR17HG gene has also been shown to be a potential biomarker for cancer, with studies showing that MIR17HG levels are significantly elevated in various types of cancer, and that inhibition of the MIR17HG gene has been shown to have diagnostic accuracy in these diseases.

In conclusion, MIR17HG is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for several diseases, including cancer. The unique structure and function of MIR17HG make it an attractive target for further research, and the potential implications of MIR17HG as a drug or biomarker make it an important area of 鈥嬧?媠tudy. Further studies are needed to fully understand the role of MIR17HG in cellular processes and its potential as a drug or biomarker for various diseases.

Protein Name: MiR-17-92a-1 Cluster Host Gene

More Common Targets

MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223